Logo image
Shingles: a harbinger of chronic HIV infection
Report   Open access

Shingles: a harbinger of chronic HIV infection

S. Zachariah, A. Sullivan and A. Donato
Journal of Community Hospital Internal Medicine Perspectives, v 11(6), pp 871-873
02 Nov 2021
PMID: 34804410
url
https://doi.org/10.1080/20009666.2021.1969080View
Published, Version of Record (VoR) Open

Abstract

herpes zoster Human immunodeficiency virus (HIV) reactivation shingles
Early diagnosis and treatment are essential to reduce the risk of community transmission and morbidity and mortality of individuals infected with HIV. A 49-year-old woman presented with a painful, vesicular rash on the left side of her neck after being treated with valacyclovir for a separate perianal rash. She admitted recent weight loss and diffuse lymphadenopathy. She reported one family member with HIV but denied intravenous drug use or recently new sexual partners. Serum HIV-1 antibody screen was positive. Herpes zoster reactivation is associated with waning immunity in chronic HIV and should prompt testing. Delays in treatment impacts short-term and long-term prognosis for patients infected with HIV.

Metrics

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Infectious Diseases
Logo image